Inozyme Pharma, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2021 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Inozyme Pharma, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2021 to Q3 2024.
  • Inozyme Pharma, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 63.3M shares, a 11.5% increase year-over-year.
  • Inozyme Pharma, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 51.8M shares, a 37.3% increase from 2022.
  • Inozyme Pharma, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 37.8M shares, a 60.3% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 63.3M +6.52M +11.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-05
Q2 2024 61.9M +17.1M +38.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 61.8M +18.1M +41.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 51.8M +14.1M +37.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-12
Q3 2023 56.8M +13.1M +30% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-05
Q2 2023 44.9M +5.16M +13% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 43.7M +20M +84.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 37.8M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-12
Q3 2022 43.7M +20M +84.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 39.7M +16.2M +69% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 23.7M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q3 2021 23.6M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 23.5M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.